Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Grabs License to Genetic Technologies Non-Coding DNA Patent

NEW YORK, April 23-Biochip company Nanogen has secured a license from the Australian firm Genetic Technologies Limited for access to non-coding DNA analysis patents, the companies said yesterday.


The license, which took effect April 12, is not exclusive, and is limited to human research and diagnostics.


Genetic Technologies said that Nanogen is paying the company cash and securities worth approximately A$620,000 (US $334,207) as an issue fee for the license.


Genetic Technologies recently granted a much broader license to Sequenom for its non-coding DNA patents, and is currently in discussions with other major United States biotech companies.


The company, which is based in Melbourne, boasts Australia's largest DNA paternity testing lab. In addition, it holds a range of international patents on non-coding (intron) DNA analysis and non-coding genomic mapping.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.